Rh(D) Alloimmunization Risk After Rh(D)-Incompatible Solid Organ Transplantations in Rh(D)-Negative Recipients.

Ari AhnJohn Jeongseok YangHee Jeong YoukDuck ChoHeung-Bum OhDae-Hyun KoSang-Hyun Hwang

Published in: American journal of clinical pathology (2022)

The low rate of Rh(D) alloimmunization is associated with the immunosuppressive state of the patients. RhIG prophylaxis seems to have no clinical benefit in Rh-i solid organ transplantation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
sickle cell disease
stem cells
cell therapy
mesenchymal stem cells